Herniarin

Herniarin

SCHEMBL62963

COc1ccc2ccc(=O)oc2c1.O=C1c2cccc1c2

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.77
CA9 Q16790 6/20 0.77
CA1 P00915 5/20 0.77
KDM4E B2RXH2 4/20 0.77
CA6 P23280 4/20 0.77
CA7 P43166 4/20 0.77
CA14 Q9ULX7 4/20 0.77
ALDH1A1 P00352 3/20 0.77
CA4 P22748 3/20 0.77
CA5A P35218 3/20 0.77
CA3 P07451 2/20 0.77
AKR1B1 P15121 1/20 0.77
HPGD P15428 1/20 0.77
HSD17B10 Q99714 1/20 0.77
NPC1 O15118 3/20 0.62
RAB9A P51151 3/20 0.62
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
CYP2A6 P11509 1/20 0.60
HTT P42858 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23114201 0.90 CYP2A6 (0.77) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL61221 0.87 CA12 (1.00) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL29437733 0.87 CA12 (1.00) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL17629468 0.87 CA12 (1.00) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL17113785 0.86 CA12 (0.96) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL593139 0.80 KDM4E (0.84) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL16752507 0.80 CA12 (0.84) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL6259517 0.80 CA12 (0.84) CA12CA9CA1KDM4ECA6
Herniarin SCHEMBL22654644 0.78 KDM4E (0.79) CA12CA9CA1KDM4ECA6
SCHEMBL17294129 0.77 PGR (0.55) CA12CA9CA1KDM4ECA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10254646-B2 Composition sensitive to radiation in electromagnetic spectrum ranges for printing purposes, printing plate comprising said composition, use of said composition and image development process IBF INDUSTRIA BRASILEIRA DE FILMES S/A (BR) 2019-04-09 US claimed
US-20160026080-A1 COMPOSITION SENSITIVE TO RADIATION IN ELECTROMAGNETIC SPECTRUM RANGES FOR PRINTING PURPOSES, PRINTING PLATE COMPRISING SAID COMPOSITION, USE OF SAID COMPOSITION AND IMAGE DEVLOPMENT PROCESS IBF INDUSTRIA BRASILEIRA DE FILMES S/A (BR) 2016-01-28 US claimed
EP-2937733-A1 COMPOSITION SENSITIVE TO RADIATION IN ELECTROMAGNETIC SPECTRUM RANGES FOR PRINTING PURPOSES, PRINTING PLATE COMPRISING SAID COMPOSITION, USE OF SAID COMPOSITION AND IMAGE DEVELOPMENT PROCESS IBF - Indústria Brasileira de Filmes S/A (BR) 2015-10-28 EP claimed
EP-4555025-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-05-13 EP disclosed
EP-3902878-B1 PHOTOINITIATORS IGM RESINS ITALIA SRL (IT) 2026-05-06 EP disclosed
EP-4534614-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-04-15 EP disclosed
EP-4722303-A1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM Group B.V. (NL) 2026-04-08 EP disclosed
EP-4273200-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-03-25 EP disclosed
US-20260071077-A1 POLYMERIC (METH)ACRYLATE PHOTOINITIATORS IGM RESINS ITALIA S.R.L. (IT) 2026-03-12 US disclosed
US-12517430-B2 Lithographic printing plate precursor ECO3 BV (BE) 2026-01-06 US disclosed
US-12487526-B2 Lithographic printing plate precursor ECO3 BV (BE) 2025-12-02 US disclosed
WO-1995012836-A1 ON-PRESS DEVELOPABLE LITHOGRAPHIC PRINTING PLATES POLAROID CORPORATION (US) 1995-05-11 WO disclosed
WO-1995012837-A1 LITHOGRAPICH PRINTING PLATES WITH PHOTOREACTIVE POLYMERIC BINDERS POLAROID CORPORATION (US) 1995-05-11 WO disclosed
US-5194365-A Method for forming images CIBA-GEIGY CORPORATION (US) 1993-03-16 US disclosed
EP-0298030-B1 PROCESS FOR FORMING IMAGES CIBA-GEIGY AG (CH) 1992-10-28 EP disclosed
US-4978604-A Process for forming images CIBA-GEIGY CORPORATION (US) 1990-12-18 US disclosed
US-4857437-A Process for the formation of an image CIBA-GEIGY CORPORATION (US) 1989-08-15 US disclosed
US-4849320-A Method of forming images CIBA-GEIGY CORPORATION (US) 1989-07-18 US disclosed
EP-0298030-A2 Process for forming images CIBA-GEIGY AG (CH) 1989-01-04 EP disclosed
EP-0294220-A2 Photopolymerizable composition Hitachi Chemical Co., Ltd. (JP) 1988-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071077-A1 POLYMERIC (METH)ACRYLATE PHOTOINITIATORS CCNY, CHRM2, CHRM5 CA12 3375/4885CA9 1887/4885CA1 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.